https://www.ibtomato.com/ExternalView.aspx?type=1&no=19113IB토마토ko2026-08-04T17:06:50+09:00bhc, 재무체력 앞세워 해외 투자…'본게임' 속도https://www.ibtomato.com/ExternalView.aspx?type=1&no=19107IB토마토ko2026-08-04T16:36:31+09:00KB금융, 비용 늘었는데 실적 효율은 개선…증권 호황 효과https://www.ibtomato.com/ExternalView.aspx?type=1&no=19104IB토마토ko2026-08-04T16:27:41+09:00DCM 양강 전략 달랐다…승부처는 하반기 금융채 빅딜https://www.ibtomato.com/ExternalView.aspx?type=1&no=19106IB토마토ko2026-08-03T18:37:06+09:00현대제철, 전기로 늘릴수록 전기료 부담…저탄소 전환의 역설https://www.ibtomato.com/ExternalView.aspx?type=1&no=19129IB토마토ko2026-08-05T17:27:01+09:00(공시톺아보기)시총 200억 밑돌면 관리종목…상폐 피하려면https://www.ibtomato.com/ExternalView.aspx?type=1&no=19123IB토마토ko2026-08-05T15:44:10+09:00(유증레이다)썸에이지, 조달액 반토막…시총 200억 못 넘으면 철회https://www.ibtomato.com/ExternalView.aspx?type=1&no=19122IB토마토ko2026-08-05T10:30:34+09:00(크레딧시그널)메리츠화재, PF 11조 노출…부동산 사업성 저하 우려https://www.ibtomato.com/ExternalView.aspx?type=1&no=19103IB토마토ko2026-08-03T17:58:18+09:00한앤컴퍼니, 마이크로웍스 매각 장기화 대비…배당 회수판 깔았다https://www.ibtomato.com/ExternalView.aspx?type=1&no=19102IB토마토ko2026-08-03T17:51:49+09:00하나카드, 트래블로그로 해외결제 45% 장악…카드이익은 제자리https://www.ibtomato.com/ExternalView.aspx?type=1&no=19100IB토마토ko2026-08-03T17:45:57+09:00아로마티카, 원료값 90% 뛰어도 원가율 하락…직거래로 방어https://www.ibtomato.com/ExternalView.aspx?type=1&no=19097IB토마토ko2026-08-03T17:37:35+09:00SKIET, 중국법인 정리에 2000억 차입…재무부담 더 커졌다https://www.ibtomato.com/ExternalView.aspx?type=1&no=19093IB토마토ko2026-08-03T17:04:09+09:00수협은행, 비이자이익 확대 늦어진다…공모운용사 인가 연말로https://www.ibtomato.com/ExternalView.aspx?type=1&no=19083IB토마토ko2026-08-03T14:07:36+09:00성호전자, AI 밸류체인 승부수…M&A 시너지 성과 '시험대'https://www.ibtomato.com/ExternalView.aspx?type=1&no=19094IB토마토ko2026-07-31T20:23:50+09:00대우건설, 시화MTV 아파트 완판에도 손실…공사비 회수 난항https://www.ibtomato.com/ExternalView.aspx?type=1&no=19092IB토마토ko2026-07-31T18:49:54+09:00HD현대중공업, 오일뱅크 빈자리 채웠다…그룹 배당 핵심축 부상https://www.ibtomato.com/ExternalView.aspx?type=1&no=19025IB토마토ko2026-08-05T06:00:00+09:00(IB&피플)최진용 루스벤처스 대표·강승순 이사https://www.ibtomato.com/ExternalView.aspx?type=1&no=19114IB토마토ko2026-08-04T16:55:04+09:00(Deal모니터)우리금융, 신종자본증권 발행했지만 차환금리 '부담'https://www.ibtomato.com/ExternalView.aspx?type=1&no=19111IB토마토ko2026-08-04T16:50:09+09:00(유증레이다)엘앤씨바이오, 1406억 유증…최대주주는 절반만 청약https://www.ibtomato.com/ExternalView.aspx?type=1&no=19108IB토마토ko2026-08-04T11:17:02+09:00(크레딧시그널)농협금융, 중앙회 1.2조 지원받아 생산적금융 확대https://www.ibtomato.com/ExternalView.aspx?type=1&no=19090IB토마토ko2026-07-31T18:18:46+09:00(반도체 메가투자)③삼성·SK, 호남 동시 출격…인력·협력사 쟁탈전https://www.ibtomato.com/ExternalView.aspx?type=1&no=19087IB토마토ko2026-07-31T18:09:31+09:00LS증권, CERCG 소송 끝냈지만…800억 PF 소송은 미충당https://www.ibtomato.com/ExternalView.aspx?type=1&no=19091IB토마토ko2026-07-31T17:56:52+09:00클로봇, 임원은 고점 매도·최대주주는 유증 외면…책임투자 도마https://www.ibtomato.com/ExternalView.aspx?type=1&no=19085IB토마토ko2026-07-31T17:36:07+09:00그린생명과학, 매출 3배 뛰자 65억 증설…상위 2곳 의존도 82%